TenQ · Equity ReportCharts view ⇢  Fact sheet  Updated 2026-09-04

Analog DevicesADI

$175.5B market cap

Makes analogue and signal-processing chips for industrial, automotive and communications customers.

$362.25-18.4% from 52-week high · delayed close as of 2026-09-04 · not investment advice
+48.5% vs S&P 500 (SPY) +20.3% over twelve months
$204.68$268.98$333.27$397.57$461.87Sep '25Nov '25Jan '26Apr '26Jun '26Sep '26
The verdict

Analog Devices in 36 checks

Analog Devices at a glance: how it scores on value, growth, quality, health, shareholder returns and trend. The fuller the shape, the stronger the company. Behind each axis are six pass-or-fail checks from its filings, spelled out in the chapters below. Point at an axis to see them.

VALUEGROWTHQUALITYHEALTHRETURNSTREND

A mixed picture - strengths and real weaknesses - 21 of 36 checks passed.

Advertisement
I

Value

●●●●●●0/6

What you pay today for what the business produces, measured against ADI's own history and its peers, never a universal rule.

Expensive against its own history and its sector - you're paying up for what you get.

44.3xown 6-year median 29x
12.6xown 6-year median 7x
2.8%cash earned per $ of price
33.7xwhole-business multiple
Today’s multiple

Is the price high or low right now, compared to what the market usually pays?

6-year median 29xP/E today 44.3x

At 44.3x earnings, the market is paying +54% more than ADI's own 6-year median of 28.8x. Expectations are elevated, so more has to go right to justify the price. Today's multiple is the highest in the charted history.

Valuation history

What has the market paid for ADI over the years?

0.0020.0040.0020162017202020212022202320266-year median 28.8xP/E 44.32

2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages

At 44.3x earnings, the market is paying +54% more than ADI's own 6-year median of 28.8x. Expectations are elevated, so more has to go right to justify the price. Today's multiple is the highest in the charted history.

Free cash flow yield

What cash return does the business throw off per dollar of market value?

2.8%FCF yield today

0.0%5.0%20162017202020212022202320266-year median 4.8%FCF yield 2.8%

2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages

At 2.8%, you get less cash per dollar of market value than the 6-year median of 4.8% - the market is charging more for the same cash.

What does “Value” actually mean?

Value asks what you pay for each dollar of earnings, sales or cash the business produces. A high multiple isn't automatically bad - fast growers earn theirs - but a price far above the company's own history means the market expects a lot to go right. We compare each multiple to the company's own past and to its sector, never to a universal rule.

How we scored it · 0 of 6 checks passed
Cheaper than its own history (earnings)no multiple history
Earnings yield beats a long bond (4%)2.3% vs 4.0%
Better cash yield than its own historyunder 3 years of cash-flow history
Free cash flow yield above 3%2.8% vs 3.0%
Cheap on enterprise value33.67 vs 14.00 (peer median)
Price isn't outrunning growthPEG 1.71
II

Growth

●●●●●●4/6

What the company has actually reported - is it selling more, and is more of it becoming profit?

Growing, but with caveats - revenue - over the last year.

-vs the year before
+30.0%compound annual
-net income growth
+25.9%compound annual
Revenue history

Revenue: is the business selling more than it used to?

0.00$5.0B$10.0B20092010201120152016201720202021202220232026$13.9B

◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year

Revenue reached $12.3B in 2023, compounding +30% a year since 2020 and the pace is picking up. The trailing twelve months are already running at $13.9B, ahead of the last full year.

Profit history

Net income: how much of that revenue becomes profit?

0.00$2.0B$4.0B20092010201120152016201720202021202220232026$4.1B

◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year

Net income was $3.3B in 2023, compounding +40% a year over three years. Trailing twelve-month profit stands at $4.1B.

Growth rate

How fast is it growing, year by year?

+2%revenue growth, FY 2023

0.0%100%2010201120152016201720202021202220232.4%21%

In 2023 revenue grew +2% while earnings moved +21% - when the earnings line runs above revenue, each new dollar of sales is arriving more profitably.

Per-share growth

Revenue per share: is your slice growing as fast as the company?

$24.32revenue per share, FY 2023

0.0010.0020.002009201020112015201620172020202120222023202627.449.76

2026 = trailing twelve months to the latest filed quarter (2026-08-01), not a full fiscal year

Revenue per share reached $24.32 in 2023, compounding +17% a year against +30% for ADI as a whole. Dilution absorbed about 12.7 points of that growth. Free cash flow per share stands at $7.03.

What does “Growth” actually mean?

Growth here is what the company has actually reported to the SEC - not a forecast. We look at the last year, the three-year pace, whether growth is speeding up or slowing down, and whether it's been consistent rather than one lucky year. Hatched bars are fourth quarters we derived from annual filings (companies file a full-year 10-K rather than a Q4 report).

How we scored it · 4 of 6 checks passed
Outgrew its sector last yearunder 8 quarters of history
Sustained growth beats its sector (3 years)30.0% vs 10.3% (sector 70th pct, n=156)
Profits grew last yearswung to a profit of $4.1B from a loss
Profit growth beats its peers25.9% vs 13.0% (sector 70th pct, n=81)
Growth is speeding up, not slowingunder 3 years of history
Grew per share, not just in total61.5% vs 0.0%
III

Quality

●●●●●●6/6

Whether the growth makes real money - margins, returns on capital, and whether profits turn into cash.

Rare profitability: margins and returns on capital are well above its peers.

65.8%kept after direct costs
35.5%kept after running costs
12.3%profit on shareholders' money
11.5%against a 10% cost of capital
134%operating cash ÷ net income
Margins

Margins: of every $1 of sales, how much survives each cost layer?

0.0%25%50%2009201020112015201620172020202120222023202666%36%30%

2026 = trailing twelve months to the latest filed quarter (2026-08-01), not a full fiscal year

Operating margin widened 4 points to 31% since 2020. After everything, 27 cents of each sales dollar reaches net profit.

Earnings quality

Earnings quality: do the reported profits turn into real cash?

0.00$2.0B$4.0B20092010201120152016201720202021202220232026$5.5B$4.1B

2026 = trailing twelve months to the latest filed quarter (2026-08-01), not a full fiscal year

Operating cash flow runs at 134% of reported profit, so the earnings are more than backed by cash - depreciation and other non-cash charges are understating what the business actually collects.

Returns on capital

What does it earn on the money it uses?

0.0%10%20%2009201020112015201620172020202120222023202612%8.5%8.4%

2026 = trailing twelve months to the latest filed quarter (2026-08-01), not a full fiscal year

ROE 9% and ROCE 8% sit close together - the returns come from the business itself, not from borrowing.

Income waterfall

Where does each dollar of revenue actually go?

$12.3BRevenue 2023$7.9BGross profit$3.8BOperating income$3.3BNet income

Of $12.3B in sales, $7.9B survives production costs, $3.8B survives running the company, and $3.3B - 27¢ of every dollar - reaches the bottom line.

Cash conversion

How much of every sales dollar ends up as free cash?

0.0%20%2009201020112015201620172020202120222023202636%

◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year

29 cents of every sales dollar became free cash in 2023, down 4 points since 2020.

Spending intensity

What does staying competitive cost, per dollar of sales?

0.0%10%20%200920102011201520162017202020212022202320264.4%14%2.5%

2026 = trailing twelve months to the latest filed quarter (2026-08-01), not a full fiscal year

The biggest claim on each sales dollar is research and development, at 13% of revenue (capital spending 10%, stock compensation 2%). That share has fallen since 2020, so the cost of competing is easing.

Operating leverage

When sales grow, do profits grow faster?

0.0%100%200%2010201120152016201720202021202220232.4%17%

Operating profit outgrew revenue in 3 of the last 5 years, most recently +17% against +2%. Each additional dollar of sales is landing more profitably than the last - the definition of operating leverage.

Return on capital employed

Does ADI earn more on its capital than that capital costs?

0.0%10%20%200920102011201520162017202020212022202310% cost-of-capital lineReturn on capital 8.4%

ADI earns 8.4% on the capital it employs, below the 10% most investors treat as the cost of capital. It was 7.6% in 2020, so the trend is up, though the pace has cooled.

What does “Quality” actually mean?

Quality asks whether the growth makes real money. Margins show how much of each sale survives costs; return on equity shows what shareholders earn on their capital; and the profit-to-cash comparison catches companies whose accounting profits never turn into actual cash.

How we scored it · 6 of 6 checks passed
Better gross margins than peers65.8% vs 44.7% (sector 70th pct, n=155)
Runs leaner than peers (operating margin)35.5% vs 8.5% (sector 70th pct, n=161)
Actually profitableTTM net income $4.1B
Earns well on shareholders' money12.3% vs 11.6% (sector 70th pct, n=149)
Earns a real return on the capital it employs11.5% vs 10.0%
Profits are cash, not accounting1.34 vs 0.80
IV

Health

●●●●●●4/6

The balance sheet stress test: could ADI survive a bad year?

Financially sound overall, with one or two things worth watching.

0.24xborrowed vs owned
1.3xnear-term bills coverage
14xearnings ÷ interest bill
$3.3Bcash plus short-term investments
Debt & cash

Could it handle its debt if things went wrong?

0.00$5.0B201220132014201520162017201820192020202120222023202420252026$8.1B$2.2B

Debt of $8.1B sits against $3.3B of cash, or 0.2x shareholders' equity. Earnings cover the interest bill 14 times over, so the debt is comfortably serviced.

Shareholders' equity

Is the company's own capital growing or shrinking?

0.00$20.0B2012201320142015201620172018201920202021$37.4B20222023202420252026$33.6B

The company's own capital shrank from $35.5B in 2023 to $33.6B (-6%). Buybacks or losses are drawing the buffer down - the distinction matters.

What does “Health” actually mean?

Health asks one question: can the business survive a bad year? We check whether near-term bills are covered, whether debt is modest and shrinking, whether earnings comfortably pay the interest, and - for loss-makers - how many years of cash are left at the current burn rate.

How we scored it · 4 of 6 checks passed
Comfortable near-term liquidity1.25 vs 1.50
Debt isn't dominating0.24 vs 1.00
Debt trending the right waydebt/equity 0.24 now vs 0.17 five years ago
Earnings cover the interest14.07 vs 5.00
Converts sales to cash better than its sector39.9% vs 16.8% (sector 70th pct, n=166)
Self-fundingTTM free cash flow $4.9B
V

Shareholder returns

●●●●●●4/6

How much cash actually flows back to owners - dividends, buybacks, whether the share count truly falls, and whether what is handed back is affordable.

Cash does come back to owners, but the share count is still climbing - part of it is recycling.

$5.2Bdividends plus buybacks
$1.7Blast fiscal year
$3.0Blast fiscal year
$300Mdilutes the buybacks
+72.9%since 2009 (as reported)
Capital returned vs stock comp

How much goes back to shareholders - and how much leaks out as stock compensation?

0.00$2.0B2009201020112015201620172020202120222023

$4.6B returned last year against $300M of stock issued to employees - the returns outweigh the dilution 15.5-to-1.

Dilution rate (split-adjusted)

How fast is your ownership being diluted - or concentrated?

0.0%20%2010201120152016201720202021202230%2023-3.3%

The count shrank 3.3% last year - buybacks are outrunning stock compensation.

Dividend per share (split-adjusted)

Is the dividend cheque itself growing?

0.002.002009201020112015201620172020202120222023DPS 3.32

Up from $1.64 to $3.32 per share over 7 years - the cheque keeps growing.

Dividend yield

What does the payout earn you at each year's prices?

0.0%2.0%2016201720202021202220232026Yield 1.0%

2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages

At today's price the yield is 1.0%.

Payout quality

Can it actually afford the dividend?

0.0%50%2009201020112015201620172020202120222023202641%34%

2026 = trailing twelve months to the latest filed quarter (2026-08-01), not a full fiscal year

Comfortable: 51% of profits and 47% of free cash flow go out as dividends - well inside what the business generates.

Dilution against what it bought

ADI has issued or retired shares - did shareholders end up better off?

02002009201020112015201620172020202120222023173353

Both lines start at 100 in 2009, so the gap between them is what each share gained or lost. Share counts are split-adjusted.

ADI issued +73% more shares from 2009 to 2023, but revenue per share still rose +253%. The dilution bought more growth than it cost existing holders.

Why compare buybacks with stock compensation?

A company can trumpet billions in buybacks while quietly issuing nearly as much stock to employees. What matters to you is the net effect: is the share count actually falling? If not, the 'return' is mostly recycling.

How we scored it · 4 of 6 checks passed
Share count isn't climbingshares up 36.0% over 3 years
Buybacks outpace the stock issued to staff$3.1B bought back vs $350M of stock compensation
What it hands back fits inside its cash flow104.7% vs 100.0%
Meaningful yield to owners (dividends and buybacks)$5.2B returned, 2.9% of market value
Reliable payer, never cutpaid 10/10 years, worst year-on-year change 4.5%
Dividend growing ahead of inflation89.5% vs 9.0%
VI

Trend analysis

●●●●●●3/6

What the market is doing about all of the above. This is price behaviour, not a fact about the business - read it as the market's current opinion, scored on six checks like every other chapter. The market is the S&P 500, measured by the SPY ETF with dividends included, over 3 months (63 trading sessions) and 12 months (252).

Mixed signals from the market - some trends up, some rolling over.

+4.6%the long-term trend line
-9.5%S&P 500 (SPY): +4.7%
+49.0%S&P 500 (SPY): +20.0%
-18.4%drawdown from peak
Trend

How is ADI's trend actually behaving right now?

Price chart loads as you scroll…

Chart by TradingView

ADI is in a downtrend. The price is below the band where recent trading settled and that band is still falling, so nothing in the picture has turned yet. Both the last two weeks and the month-ago comparison point down as well, so nothing here disagrees with the downtrend.

How the trend above is worked out

The trend read comes from the daily Ichimoku picture, a standard trend indicator, translated out of its jargon. It builds a band from the midpoints of the last 9, 26 and 52 sessions' highs and lows - in effect, the range where recent trading has settled - and draws that band 26 sessions into the future. Price above the band is an uptrend, below it a downtrend, inside it no trend. Because the band is drawn forward, the support for the next few weeks is already fixed and a change of its direction can be seen coming. We also compare the last two weeks against the last month, and today's price against where it stood a month ago. None of this says anything about the business; it describes the price only, and it is not advice. Where a check says 'the S&P 500', the comparison is with the SPY ETF including dividends, on the same adjusted basis as the stock's own price: short means 3 months, 63 trading sessions; long means 12 months, 252.

How we scored it · 3 of 6 checks passed
Trading above its cloud0.00 vs 0.50
Long-term trend structure is healthy376.31 vs 346.29
Rising over 3 months-9.5% vs 0.0%
Beating the S&P 500 over 3 months-9.5% vs 4.7%
Beating the S&P 500 over 12 months49.0% vs 20.0%
Not in a deep hole-18.4% from its 52-week high
VII

Insider activity

informational

What the people running the company do with their own shares - reported to the SEC within two days, classified so pay-plumbing doesn't masquerade as conviction.

$0.00their own money
$16Moften pre-scheduled
51of the last filings
9grants · exercises · tax
Open-market flow

Are the people running it buying or selling with their own money?

$20M0.00Apr '26May '26Jun '26Jul '26Aug '26Sep '26

No open-market buying, and $16M of selling across 6 months. Selling alone is a weak signal - much of it is pre-scheduled - but the absence of buying tells you no insider saw the price as a bargain.

The record

Who did what, exactly?

DateInsiderRoleTypeSharesValue
2026-09-01Vincent RocheChair & CEOexercise10,000$1M
2026-09-01Vincent RocheChair & CEOSELL10,000$4M
2026-08-27Karen GolzDirectorSELL1,000$374,500
2026-08-26Richard C Jr PuccioEVP and CFOSELL2,683$1M
2026-08-17Michael SondelCAO (principal acct. officer)tax237$92,652
2026-08-17Vincent RocheChair & CEOtax2,878$1M
2026-08-17Richard C Jr PuccioEVP and CFOtax1,108$432,502
2026-08-17Katsufumi NakamuraSVP, Chief Customer Officertax202$78,688
2026-08-17Vivek JainEVP, Global Operationstax1,111$433,627
2026-08-17Martin CotterSVP, Vertical Business Unitstax705$275,126
Why do the transaction types matter so much?

Most insider filings are not trades: stock grants, option exercises and tax withholding are how executives get paid, and gifts are estate planning. The signal lives in open-market transactions - a buy means an insider chose to spend their own cash on the stock. Sells are murkier: many are pre-scheduled 10b5-1 plans set months in advance. That's why the chart counts only open-market activity, and the table labels every row.

§

Recent filings

  • 10-Q Quarterly report
  • 10-Q Quarterly report
  • 10-Q Quarterly report
  • DEF 14A Proxy statement
  • 10-K Annual report
  • 10-Q Quarterly report
  • 10-Q Quarterly report
  • 10-Q Quarterly report
A short weekly note on what changed in the numbers, coming soon.One email a week: the charts that mattered, nothing else.